I found the management team, the project managers, and the monitors to be highly professional, very responsive to requests for both information and action, and knowledgeable about both GCP and the unique requirements of oncology clinical trials."

– M.D., QD Consulting, LLC

"It was a pleasure working with somebody who anticipated the needs of the sponsor and always delivered or over-delivered. From the initial interactions to study start-up, enrollment/dosing, monitoring, and closeout, I could not have been happier with [their] flexibility and professionalism."

– J. D., Epiphany Biosciences

"They played an integral part in not only the development of our over study plan, but specifically the development of essential documents: protocol, informed consent forms, case report forms, and a variety of study plans, specifically the monitoring plan and communication plan."

– D K-H, Eli Lilly and Co.

"To date, all of my clients have spoken very highly of each and every MedSource monitor placed on their studies."

– T. B. S., North America MDS Pharma Services, Inc.

“I love working with MedSource and do not want anything to change. Every issue that has come up, your team has quickly come up with a solution. They have been great to work with and deliver quality work. “

– Executive Director Clinical Development

“MedSource is very concerned with fostering the client relationship and is extremely helpful and supportive on all levels.”


“I like the project management team, really good as far as keeping us in the loop, feel like we are part of their team. They include us in all meetings and communications for the project.”

– Director, Clinical Operations

“One of the biggest things I respect about them is they admit when they can’t do something. They never offered to sell us a study they weren’t able to do or hadn’t done before, even though they could have. They only offer services that they know they have expertise in.”

– Sr. Director, Head of Clinical Operations

“Our company has been very pleased with MedSource and our performance."

– VP, Clinical Operations

…more text.